Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY: BSX )

100.56 +1.64 (+1.66%)
Streaming Delayed Price Updated: 11:53 AM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Why Boston Scientific (BSX) Stock Is Up Today
Shares of medical device company Boston Scientific (NYSE:BSX) jumped 8.5% in the pre-market session after the company reported first quarter 2025 results that beat analysts' sales and EPS expectations.... 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Stocks Surge On China Tariff Hopes, Tesla Jumps, Gold Loses Shine: What's Driving Markets Wednesday?
Risk-on sentiment dominated Wall Street on Wednesday, as upbeat earnings reports and conciliatory messages from the Trump administration helped lift investor confidence. 
Via Benzinga
Topics Government
Exposures Political
Earnings Scheduled For April 23, 2025
Via Benzinga
Boston Scientific Stock Jumps On Strong Q1 Earnings, Upbeat Full-Year Guidance: But Retail’s Unmoved
CEO Mike Mahoney said that the company remains “well-positioned” for the future after an “exceptional quarter.” 
Via Stocktwits
Exposures COVID-19 Product Safety
What's going on in today's pre-market session: S&P500 movers
Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition
Boston Scientific topped Q1 revenue and EPS forecasts, lifted its 2025 outlook, and announced CFO Dan Brennan's retirement after nearly 30 years. 
Via Benzinga
Topics Retirement
Exposures Pension
Boston Scientific Stock Jets 8% Higher On Solid Quarterly Beat, Hiked Guidance
Boston Scientific stock jumped Wednesday after the medtech company beat first-quarter expectations and hiked its sales view. 
Via Investor's Business Daily
Topics Retirement
Exposures Pension
Earnings Preview: Boston Scientific
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Integer Holdings (ITGR) Q1 Earnings: What To Expect
Medical technology company Integer Holdings (NYSE:ITGR) will be reporting earnings tomorrow before market hours. Here’s what you need to know. 
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Merit Medical Systems (MMSI) Q1 Earnings: What To Expect
Medical device company Merit Medical Systems (NASDAQ:MMSI) will be announcing earnings results tomorrow after the bell. Here’s what investors should know. 
Via StockStory
Boston Scientific (NYSE:BSX) Beats Q1 Sales Targets, Next Quarter’s Sales Guidance is Optimistic
Medical device company Boston Scientific (NYSE:BSX) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, with sales up 20.9% year on year to $4.66 billion. Guidance for next quarter’s... 
Via StockStory
What To Expect From Boston Scientific’s (BSX) Q1 Earnings
Medical device company Boston Scientific (NYSE:BSX) will be reporting results tomorrow before market open. Here’s what to look for. 
Via StockStory
Topics Economy
Exposures Interest Rates
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
The Benzinga Stock Whisper Index highlights five stocks that saw higher than usual searches and a look at the potential catalysts surrounding the names. 
Via Benzinga
This Boston Scientific Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga
A Glimpse Into The Expert Outlook On Boston Scientific Through 13 Analysts
Via Benzinga
Is Boston Scientific Gaining or Losing Market Support?
Via Benzinga
3 Market-Beating Stocks with Competitive Advantages
Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the... 
Via StockStory
Trump Tariffs Spare Drugmakers But Threaten Diabetes Device Industry
Trump's 10% global tariff spares pharmaceuticals but impacts medical devices, with diabetes device makers facing the greatest strain. Large biopharma firms remain protected, while medtech companies... 
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
Q4 Rundown: Abbott Laboratories (NYSE:ABT) Vs Other Medical Devices & Supplies - Diversified Stocks
Let’s dig into the relative performance of Abbott Laboratories (NYSE:ABT) and its peers as we unravel the now-completed Q4 medical devices & supplies - diversified earnings season. 
Via StockStory
Price Over Earnings Overview: Boston Scientific
Via Benzinga
What's going on in today's session: S&P500 gap up and gap down stocks
Seeking insights into today's market movers? Discover the S&P500 gap up and gap down stocks in today's session on Wednesday. Stay informed about the latest market trends. 
Via Chartmill
Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock
Via Benzinga
$100 Invested In Boston Scientific 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Is BOSTON SCIENTIFIC CORP (NYSE:BSX) suited for high growth investing?
A fundamental and technical analysis of (NYSE:BSX): BOSTON SCIENTIFIC CORP (NYSE:BSX) may be suited for high growth investing, we'll explore why in this article. 
Via Chartmill
Would Mark Minervini consider BOSTON SCIENTIFIC CORP (NYSE:BSX) a top stock pick?
A fundamental and technical analysis of (NYSE:BSX): Why BOSTON SCIENTIFIC CORP (NYSE:BSX) is Poised for High Growth. 
Via Chartmill
Q4 Earnings Roundup: CooperCompanies (NASDAQ:COO) And The Rest Of The Medical Devices & Supplies - Diversified Segment
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, including CooperCompanies (NASDAQ:COO) and its peers. 
Via StockStory
Goldman Sachs Gains Confidence In Market Rebound, Upgrades GE Healthcare Amid China Recovery Hopes
Goldman Sachs upgrades GE Healthcare to Buy, raising its price target to $100, as analysts see market stabilization and China sales recovering faster than expected. 
Via Benzinga
2 Reasons to Like BSX (and 1 Not So Much)
Since March 2020, the S&P 500 has delivered a total return of 97.5%. But one standout stock has nearly doubled the market - over the past five years, Boston Scientific has surged 176% to $97 per share.... 
Via StockStory
Topics Stocks
Exposures US Equities
ResMed Among Top Stocks For Recent And Long-Term Profit Growth
A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue? 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.